Delivery Order SPE2DB22D2206-SPE2DB24FEL53
Award Date 12/4/23
Potential Completion Date 12/26/23
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $116,823.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of PADCEV 30 MG VIALS, and has an ultimate completion date of January 9, 2024. The contract is a firm fixed-price arrangement, and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of PADCEV 30 MG VIALS. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $5,543.80 and a period of performance through March 27, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $27,719.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of PADCEV 30 MG VIALS, with an ultimate completion date of April 4, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This federal contract award, valued at $18,479.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PADCEV 20 MG VIALS, a pharmaceutical product, with a completion date of March 25, 2025. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,364.50 firm fixed-price delivery order is for the medical product PADCEV 20 MG VIALS. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for the company to deliver a comprehensive range of...
- This federal contract award, valued at $14,999.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product PADCEV 30 MG VIALS and has a completion date of June 11, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, is delivering these items without any set-aside designation. This contract is associated with a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $48,676.60, is a Firm Fixed Price Delivery Order for the supply of PADCEV 30 MG VIALS. This contract award is not designated as a set-aside and was awarded through full and open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also...
- The U.S. Department of Defense (DoD) Defense Logistics Agency (DLA) awarded a $24,999.30 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of PADCEV 30 MG vials, a pharmaceutical product, with a period of performance through October 28, 2024. AmerisourceBergen is a large pharmaceutical distributor that provides a wide range of medical commodities to federal agencies, including the military. This contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $25,863.30, is for the delivery of PADCEV 30 MG VIALS, a pharmaceutical product. This delivery order falls under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $14,999.58 for the supply of PADCEV 30 MG vials. The contract is a firm fixed-price award with an ultimate completion date of November 26, 2024. It was placed by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and does not have a set-aside designation, indicating open competition. AmerisourceBergen is a major pharmaceutical distributor that maintains a $999,999,999 Indefinite...